Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Election 2016: A Scientist Reflects

Posted on November 15th, 2016 by in Pharma R&D

Like many of my science colleagues in the U.S., I was gobsmacked by the outcome of the presidential election last Tuesday. With some exceptions, most of my academic and industry colleagues were supporting the Clinton campaign in the general election. Continue reading “The Election 2016: A Scientist Reflects” »

What Does the 2016 US Election Mean For Pharma?

Posted on June 28th, 2016 by in Pharma R&D

With summer, the 2016 U.S. Presidential Election is now truly heating up as we have presumptive nominees from the two major political parties. While we are hearing a lot about issues like national security and immigration from Republican nominee Donald Trump and Democratic nominee Hillary Clinton, those working in the pharmaceutical industry may be wondering how their sector will be affected by the eventual winner. Continue reading “What Does the 2016 US Election Mean For Pharma?” »